| CTRI Number |
CTRI/2022/01/039389 [Registered on: 13/01/2022] Trial Registered Prospectively |
| Last Modified On: |
11/01/2022 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
A clinical analysis of incidence of Urinary tract infection and stent related symptoms in patients following surgery for renal stones. |
|
Scientific Title of Study
|
A clinical randomised analysis of incidence of Urinary tract infection and stent related symptoms in patients with peri interventional antibiotic prophylaxis only versus low dose continuous antibiotic treatment in patients with DJ stent. |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Pramod Makannavar |
| Designation |
Assistant Professor |
| Affiliation |
SDM Medical college and hospital, |
| Address |
Department of Urology
SDM Kedical college and hospital
Sattur
Dharwad Department of Urology
SDM Medical college and hospital
Sattur
Dharwad, 580009 Dharwad KARNATAKA 580009 India |
| Phone |
8971883525 |
| Fax |
918662461651 |
| Email |
drpramod.0702@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Pramod Makannavar |
| Designation |
Assistant Professor |
| Affiliation |
SDM Medical college and hospital, |
| Address |
Department of Urology
SDM Medical college and hospital
Sattur
Dharwad, 580009 Department of Urology
SDM Medical college and hospital
Sattur
Dharwad, 580009 Dharwad KARNATAKA 580009 India |
| Phone |
8971883525 |
| Fax |
918662461651 |
| Email |
drpramod.0702@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Pramod Makannavar |
| Designation |
Assistant Professor |
| Affiliation |
SDM Medical college and hospital, |
| Address |
Department of Urology
SDM Medical college and hospital
Sattur
Dharwad, 580009 Department of Urology
SDM Medical college and hospital
Sattur
Dharwad, 580009 Dharwad KARNATAKA 580009 India |
| Phone |
8971883525 |
| Fax |
918662461651 |
| Email |
drpramod.0702@gmail.com |
|
|
Source of Monetary or Material Support
|
| SDM Medical college and hospital
Sattur
Dharwad, Karnataka |
|
|
Primary Sponsor
|
| Name |
Pramod Makannavar |
| Address |
Department of Urology
SDM Medical college and hospital
Sattur
Dharwad, 580009
Karnataka
|
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| pramod makannavar |
Department of Urology, SDM Medical college |
Sattur
Dharwad, 580009 Dharwad KARNATAKA |
8971883525 918662461651 drpramod.0702@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| SDM institutional ethics committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: N202||Calculus of kidney with calculus of ureter, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
low dose continuous antibiotic treatment for entire stent indwelling time. |
Patients who have undergone endourological procedures for uncomplicated upper urinary tract urolithiasis and who are on double j stent (DJ stent) and those who fulfill inclusion criteria will be included in comparator group. These patients along with peri interventional antibiotic prophylaxis will also receive low dose continuous antibiotic treatment for entire stent indwelling time, that is nitrofurantoine tablet 100 mg at bedtime from the time of discharge up to removal of stent (4 weeks). |
| Intervention |
Peri interventional antibiotic prophylaxis only |
Patients who have undergone endourological procedures for uncomplicated upper urinary tract urolithiasis and who are on double j stent (DJ stent) and those who fulfill inclusion criteria will be included in intervention group. These patients will be given only perioperative antibiotics, that is intravenous cefotaxime 1 gm at the time of anaesthesia induction and twice per day on post operative for 1 day. No continuous antibiotic prophylaxis for entire stent indwelling time. |
|
|
Inclusion Criteria
|
| Age From |
14.00 Year(s) |
| Age To |
75.00 Year(s) |
| Gender |
Both |
| Details |
sterile urine culture prior to procedure,
complete stone clearance,
no fever or antibiotic treatment within past 2 weeks of procedure. |
|
| ExclusionCriteria |
| Details |
Positive urine culture prior to surgery,
incomplete stone clearance,
patients who are already on antibiotics. |
|
|
Method of Generating Random Sequence
|
Coin toss, Lottery, toss of dice, shuffling cards etc |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| incidence of Urinary tract infection and stent related symptoms in patients with peri interventional antibiotic prophylaxis only versus low dose continuous antibiotic treatment in patients with (double j)DJ stent. |
incidence of Urinary tract infection and stent related symptoms in patients with peri interventional antibiotic prophylaxis only versus low dose continuous antibiotic treatment in patients with (double j)DJ stent. Patients will be assessed at 1,2 and 4 weeks following surgery with symptoms pertaning to stent insitu and urine culture. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Patients will also be assessed for drug related side effects like gastrointestinal side effects and respiratory symptoms in those who have been given continuous antibiotic treatment for entire stent indwelling time. |
patients will be assessed at 1,2 and 4 weeks of follow up. |
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/03/2022 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
nil |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol
- Who will be able to view these files?
Response - Researchers who provide a methodologically sound proposal.
- For what types of analyses will this data be available?
Response - To achieve aims in the approved proposal.
- By what mechanism will data be made available?
Response - Proposals should be directed to [drpramod.0702@gmail.com].
- For how long will this data be available start date provided 08-04-2023 and end date provided 08-04-2025?
Response - Beginning 9 months and ending 36 months following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - nil
|
|
Brief Summary
|
Introduction: Placement of double J stent (DJ stent) is routine following endourological surgical interventions for urinary tract stone disease. Main complications following these procedures are urinary tract infection (UTI) and stent related symptoms (SRS ), which hamper daily activities. There is lack of literature about appropriate antibiotic strategy following uncomplicated endourological surgery for upper urinary tract stone disease in patients who are on DJ stent. Many clinicians give a continuous low dose antibiotic treatment for entire stent indwelling time to prevent UTI and also possibly reduce SRS. Our study will be conducted to evaluate incidence of UTI and stent related symptoms (SRS) in patients given a peri interventional antibiotic prophylaxis only vs a continuous low dose antibiotic treatment for entire stent indwelling time. Objectives: To evaluate incidence of UTI and SRS in patients given a peri interventional antibiotic prophylaxis only vs a continuous low dose antibiotic treatment for entire stent indwelling time.Also to note any drug related side effects. Methods: All patients will be evaluated with thorough medical history, physical examination, blood chemistry test, midstream urine sample analysis and culture. All patients will receive peri interventional antibiotic prophylaxis that is intravenous cefotaxime 1 gm at the time of anaesthesia induction. Patients who had complete stone clearance with DJ stent placed will be selected for the study. Patients will be randomised into 2 groups by lottery method or odd or even number. Group A – No antibiotic treatment from the time of discharge up to removal of the stent (4 weeks). Group B – Low dose continuous antibiotic treatment for entire stent indwelling time, that is nitrofurantoine tablet 100 mg at bedtime from the time of discharge up to removal of stent (4 weeks). Inclusion criteria - sterile urine culture prior to procedure, complete stone clearance, no fever or antibiotic treatment within past 2 weeks of procedure. Exclusion criteria – Positive urine culture prior to surgery, incomplete stone clearance, patients who are already on antibiotics. Total sample of 100 cases will be considered through convenience type of sampling (on an average 8-10 patients are operated for upper urinary tract urolithiasis in an month, overall 120 cases in an year. Considering 10% may not be willing to give consent and10% may not fit into inclusion criteria). Of these 100 patients, 2 groups will be made with 50 patients in each group. Follow-up evaluation Patients will be evaluated at 1, 2 and 4 weeks for Stent related symptoms and urine culture evaluation. Clinical symptoms of UTI and SRS are very similar, therefore positive urine culture will be used to distinguish UTI from SRS. Clinical symptoms with positive urine culture will be considered as UTI, and clinical symptoms with negative urine culture will be considered symptoms related to stent insitu. Our primary objective will be UTI and secondary objective will be SRS and drug side effects. Any patients with symptomatic UTI will be given full dose antibiotic treatment according to antibiotic resistance pattern. Drug side effects will also be evaluated like gastro intestinal symptoms, cough. .
|